Tumor-induced rickets: Usefulness of MR gradient echo recall imaging for tumor localization

Journal of Pediatrics

Volumn 144, Issue 3, 2004, Pages 381-385

  Shulman, Dorothy I ^a   Hahn, Gregory ^b   Benator, Richard ^b   Washington, Kenneth ^b   White, Kenneth E ^b   Farber, Joshua ^b   Econs, Michael J ^b  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PHOSPHATE;

ANAMNESIS; ARTICLE; BONE MINERALIZATION; BONE TUMOR; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; ECHOGRAPHY; FEMUR FRACTURE; HUMAN; HYPOPHOSPHATEMIA; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RICKETS; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 1542511325     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.11.023     Document Type: Article

References (17)

1. Econs MJ, Drezner MK. Tumor induced osteomalacia-unveiling a new hormone. N Engl J Med 1994;330:1679-81.
2. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, et al. Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 1994;330:1645-9.
3. White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 2001;86:497-500.
4. Nuovo MA, Dorfman HD, Sun CC, Chalew SA. Tumor-induced osteomalacia and rickets. Am J Surg Pathol 1989;13:588-99.
5. Weidner N. Review and update: oncogenic osteomalacia-rickets. Ultrastruct Pathol 1991;15:317-33.
6. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-5.
7. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002;87:4957-60.
8. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-63.
9. Bachrach LK, Hastie R, Wang M-C, Narasimhan B, Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999;84:4702-12.
10. Vanel D, Bittoun J, Tardivon A. MRI of bone metastases. Eur Radiol 1998;8:1345-51.
11. Prader VA, Illig R, Vchlinger E, Stalder G. Rachitis, infolge, knochen tumors. Helv Paediatr Acta 1959;14:554-65.
12. Reyes-Mugica M, Arnsmeier SL, Packeljauw PF, Persing J, Ellis B, Carpenter TO. Phosphaturic mesenchymal tumor-induced rickets. Pediatr Dev Pathol 2000;3:61-9.
13. Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001;345:1883-8.
14. Avila NA, Skarulis M, Rubino DM, Doppman JL. Oncogenic osteomalacia: lesion detection by MR skeletal survey. Am J Radiol 1996;167:343-5.
15. Sundaram M, McCarthy EF. Oncogenic osteomalacia. Skeletal Radiol 2000;29:117-24.
16. Ryan EA, Reiss E. Oncogenous osteomalacia: review of the world literature of 42 cases and report of two new cases. Am J Med 1984;77:501-12.
17. Whyte MP, Podgornik MN, Wollberg VA, Eddy MC, McAlister WH. Pseudo-(tumor-induced) rickets. J Bone Miner Res 2001;8:1564-71.